• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Improving case fatality ratio estimates in ongoing pandemics through case-to-death time distribution analysis

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Feb 13;15(1):5402.
doi: 10.1038/s41598-025-89441-y. Improving case fatality ratio estimates in ongoing pandemics through case-to-death time distribution analysis

Zia Farooq[SUP] 1 [/SUP], Henrik Sjödin[SUP] 2 [/SUP], Joacim Rocklöv[SUP] 2 3 [/SUP], Åke Brännström[SUP] 4 5 [/SUP]



Affiliations
Abstract

The case fatality ratio (CFR) is a vital metric for assessing the disease severity of novel pathogens. The widely used direct method of CFR estimation-the ratio of total confirmed deaths to total confirmed cases-is inherently simplistic, as it fails to account for the essential time lag between case confirmation to death, and reporting delays. These limitations often lead to biased CFR estimates, particularly in the early stages of outbreaks. This study introduces a novel approach-the distributed-delay method that, like the direct method, utilizes publicly available aggregate time-series data on cases and deaths. It estimates CFR by flexibly incorporating a case-to-death time distribution without requiring a priori assumptions on distribution parameters. Using a fitting approach to forecast case fatalities based on known or assumed case-to-death time distributions, the method consistently recovers true CFR much earlier than the direct method under various simulation settings. These settings reflect variability in disease severity, uncertainties in case-to-death time parameters, and limited knowledge of case-to-death time distributions. It outperforms other methods such as Baud's, which assumes a non-zero constant case-to-death time, and the Generalized Baud's method, which allows for a direct comparison with our new approach. While evaluations based on empirical data are challenging, our conclusions are supported by CFR estimates obtained using empirical COVID-19 data from 34 countries. As an added value, this analysis also demonstrates a significant negative association between eventual CFR and the expected case-to-death time within the context of COVID-19 data. Our study highlights the complexities of inferring real-time CFR from aggregate time-series case and death data, highlighting that refining this method can lead to accurate real-time CFR estimations for actual outbreaks.

Keywords: CFR; COVID-19; Case fatality ratio; Case-to-death times; Distributed-delay method; Particle-swarm optimization.

 
Back
Top Bottom